checkAd

     117  0 Kommentare Twist Bioscience Launches Rapid Turnaround, Customizable Panels to Advance R&D in Minimal Residual Disease (MRD) Detection in Cancer Screening - Seite 3

    Follow us on Twitter | Facebook | LinkedIn | YouTube

    1 Twist NGS products are intended for research use only; not for use in diagnostic procedures

    Diskutieren Sie über die enthaltenen Werte


    Business Wire (engl.)
    0 Follower
    Autor folgen

    Weitere Artikel des Autors

    Seite 3 von 3

    Twist Bioscience Launches Rapid Turnaround, Customizable Panels to Advance R&D in Minimal Residual Disease (MRD) Detection in Cancer Screening - Seite 3 Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the launch of the Twist MRD Rapid 500 Panel1, a custom solution that …

    Schreibe Deinen Kommentar

    Disclaimer